Skip to main content
. Author manuscript; available in PMC: 2009 Feb 27.
Published in final edited form as: Science. 2008 Dec 5;322(5907):1562–1565. doi: 10.1126/science.1164511

Table 1.

Maternal microchimerism in fetal LNs. We analyzed fetal mesenteric lymph nodes (18 to 22 g.w.) for levels of maternal microchimerism with the use of two separate assays (16). Informative HLA types and/or insertion/deletion (in/del) polymorphisms are listed for each donor. “None” refers to situations where no informative HLA type or polymorphisms were identified; “Neg.” refers to samples where no microchimerism was detected; N.A., not applicable.

Sample number HLA type/(in/del) marker % Microchimerism (HLA type) % Microchimerism (in/del)
1 DR13/SO10 0.3860% 0.3080%
2 None/SO3 N.A. 0.1640%
3 DR11/None 0.8260% N.A.
4 DR4/None 0.0035% N.A.
5 None/None N.A. N.A.
6 DR9/SO7B 0.0370% 0.0906%
7 DR1/SO6 0.0650% 0.0190%
8 DR13/None Neg. N.A.
9 DR7/SO8 0.1780% 0.4934%
10 SO6/None 0.0062% N.A.
11 None/SO9
SO10
N.A. 0.0070%
0.0039%
12 DR1/SO4B 0.0312% 0.0234%
13 None/SO9
SO11
N.A. 0.4869%
0.1933%
14 DR1/None 0.3663% N.A.
15 DR15/SO3 Neg. Neg.
16 DR11/None 0.0114% N.A.
17 DR15/SO3 0.0161% 0.006%
18 DR15/None 0.1158% N.A.